Virus exposure and neurodegenerative disease risk across national biobanks

Kristin S. Levine
Hampton L. Leonard
Cornelis Blauwendraat
Hirotaka Iwaki
Nicholas Johnson
Sara Bandres-Ciga
Luigi Ferrucci
Faraz Faghri
Andrew B. Singleton
Mike A. Nalls

Read the full article

Listed in

@nickomatics's saved articles (nickomatics)

Log in to save this article

Abstract

No abstract available

Version published to 10.1016/j.neuron.2022.12.029
Apr 1, 2023
Version published to 10.1101/2022.07.08.22277373 on medRxiv
Jul 10, 2022

Adult Vaccination History and Plasma Biomarker Signatures in the Asymptomatic PREVENT-AD Cohort

This article has 7 authors:
1. Sophie Charland
2. Mélissa Savard
3. Isabel Sarty
4. Christine Dery
5. Sylvia Villeneuve
6. Cynthia Picard
7. Judes Poirier
This article has no evaluationsLatest version Aug 27, 2026
TMEM106B analysis in diverse cohorts suggests no association with Parkinson’s disease risk

This article has 5 authors:
1. Henry Mauricio Chaparro-Solano
2. Sajanth Kanagasingam
3. Ziv Gan-Or
4. Konstantin Senkevich
5. the Global Parkinson’s Genetic Program (GP2)
This article has no evaluationsLatest version Oct 2, 2026
Predicting COVID-19 hospitalisation and common disease risk from comorbid diagnoses in 13 million individuals

This article has 7 authors:
1. Hongjiao Liu
2. Mehrdad A. Mizani
3. Yujie Zhao
4. Angela Wood
5. Michael Inouye
6. Alkes L. Price
7. Xilin Jiang
This article has no evaluationsLatest version Sep 1, 2026